Skip to main content
Funded Studies

Armin Giese, Prof. Dr. med., MD

Chief Scientific Officer at MODAG GmbH

Location: Wendelsheim Germany

Prior to joining MODAG as CSO, Prof. Dr. Giese was Acting Head of Department at the Center for Neuropathology and Prion Research (ZNP) at the University of Munich and Acting Head of the German Reference Center for Neurodegenerative Diseases (DGNN). He holds a Bachelor of Science from the University College London, Medical Licenses from the University of Kiel, and a Doctor of Medicine from the University of Göttingen.

Dr. Giese is a board-certified neuropathologist, and has published over 150 scientific publications, cited more than 14,000 times. His scientific work focuses on the role of protein aggregation in neurodegenerative diseases. Prof. Dr. Giese developed new high-throughput methods for the detection of protein oligomers and for the screening of aggregation inhibitors based on single particle spectroscopy. Utilizing this technology, he identified novel aggregation inhibitors with excellent medical-chemical properties and high in vivo efficacy. Based on these findings, he co-founded MODAG in 2013.


Associated Grants

  • Anle138b Clinical Phase 1 Studies: Food Effect, Safety and Tolerability as well as Pharmacokinetics in Parkinson´s Disease Patients

    2020


  • Pre-clinical Development of the Oligomer Modulator anle138b and Establishment of a Novel Seeding-based Biomarker

    2015


  • Evaluation of the Oligomer Modulator anle138b in a Seeding-based Model of Parkinson’s Disease

    2014


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.